Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol. 2008;3:11–40. https://doi.org/10.1146/annurev.pathmechdis.3.121806.154326.

Article  CAS  PubMed  Google Scholar 

Prusiner SB, Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363–83. https://doi.org/10.1073/pnas.95.23.13363.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bishop MT, Will RG, Manson JC. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A. 2010;107(26):12005–10. https://doi.org/10.1073/pnas.1004688107.

Article  PubMed  PubMed Central  Google Scholar 

Laske C, Gefeller O, Pfahlberg A, Zerr I, Schröter A, Poser S. The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a german pilot case-control study. Eur J Epidemiol. 1999;15(7):631–5. https://doi.org/10.1023/a:1007683208121.

Article  CAS  PubMed  Google Scholar 

Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet. 1999;353(9154):693–7. https://doi.org/10.1016/s0140-6736(98)08138-0.

Article  CAS  PubMed  Google Scholar 

Ruegger J, Stoeck K, Amsler L, et al. A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001–2004. BMC Public Health. 2009;9:18. https://doi.org/10.1186/1471-2458-9-18.

Article  PubMed  PubMed Central  Google Scholar 

van Duijn CM, Delasnerie-Laupretre N, Masullo C, et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet. 1998;351(9109):1081–5. https://doi.org/10.1016/s0140-6736(97)09468-3.

Article  PubMed  Google Scholar 

Ward HJ, Everington D, Croes EA, et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology. 2002;59(4):543–8. https://doi.org/10.1212/wnl.59.4.543.

Article  CAS  PubMed  Google Scholar 

Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda MJ, et al. Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology. 2008;31(4):229–40. https://doi.org/10.1159/000163097.

Article  PubMed  PubMed Central  Google Scholar 

de Pedro-Cuesta J, Mahillo-Fernández I, Rábano A, et al. Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry. 2011;82(2):204–12. https://doi.org/10.1136/jnnp.2009.188425.

Article  PubMed  Google Scholar 

Molesworth AM, Mackenzie J, Everington D, Knight RS, Will RG. Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom. Transfusion. 2011;51(8):1872-3; author reply 3–4. https://doi.org/10.1111/j.1537-2995.2011.03198.x

de Pedro Cuesta J, Ruiz Tovar M, Ward H, et al. Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease. Neuroepidemiology. 2012;39(1):1–18. https://doi.org/10.1159/000339318.

Article  PubMed  Google Scholar 

Uttley L, Carroll C, Wong R, Hilton DA, Stevenson M. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2–e10. https://doi.org/10.1016/s1473-3099(19)30615-2.

Article  PubMed  Google Scholar 

Klug GM, Wand H, Simpson M, et al. Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry. 2013;84(12):1372–7. https://doi.org/10.1136/jnnp-2012-304820.

Article  PubMed  Google Scholar 

Carstensen B. Age–period–cohort models for the Lexis diagram. Stat Med. 2007;26(15):3018–45. https://doi.org/10.1002/sim.2764.

Article  CAS  PubMed  Google Scholar 

Cohen CH. Does improvement in case ascertainment explain the increase in sporadic Creutzfeldt-Jakob disease since 1970 in the United Kingdom? Am J Epidemiol. 2000;152(5):474–9. https://doi.org/10.1093/aje/152.5.474.

Article  CAS  PubMed  Google Scholar 

Rutherford MJ, Lambert PC, Thompson JR. Age–period–cohort modeling. Stata J. 2010;10(4):606–27. https://doi.org/10.1177/1536867x1101000405.

Article  Google Scholar 

Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: age–period and age–cohort models. Stat Med. 1987;6(4):449–67. https://doi.org/10.1002/sim.4780060405.

Article  CAS  PubMed  Google Scholar 

Sun Y, Liu CC, Fan LY, et al. Incidence of and Mortality due to Human Prion Diseases in Taiwan: a prospective 20-Year Nationwide Surveillance Study from 1998 to 2017. Clin Epidemiol. 2020;12:1073–81. https://doi.org/10.2147/clep.s274093.

Article  PubMed  PubMed Central  Google Scholar 

Coulthart MB, Jansen GH, Connolly T et al. Creutzfeldt-Jakob disease mortality in Canada, 1998 to 2013. Canada communicable disease report = Releve des maladies transmissibles au Canada. 2015;41(8):182–91. https://doi.org/10.14745/ccdr.v41i08a01

Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133(10):3043–57. https://doi.org/10.1093/brain/awq216.

Article  PubMed  Google Scholar 

Cousens SN, Zeidler M, Esmonde TF et al. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96. BMJ (Clinical research ed.). 1997;315(7105):389–95. https://doi.org/10.1136/bmj.315.7105.389

Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer’s disease in Europe: a meta-analysis. Neurologia. 2017;32(8):523–32. https://doi.org/10.1016/j.nrl.2016.02.016.

Article  CAS  PubMed  Google Scholar 

Heinemann U, Krasnianski A, Meissner B, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(Pt 5):1350–9. https://doi.org/10.1093/brain/awm063.

Article  CAS  PubMed  Google Scholar 

Plaitakis A, Viskadouraki AK, Tzagournissakis M, et al. Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate of PRNP 129-methionine homozygosity in the local population. Ann Neurol. 2001;50(2):227–33.

Article  CAS  PubMed  Google Scholar 

Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci. 1990;95(3):239–58. https://doi.org/10.1016/0022-510x(90)90072-u.

Article  CAS  PubMed  Google Scholar 

Mendez MF, Mastri AR, Sung JH, Frey WH. 2nd. Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord. 1992;6(1):35–43. https://doi.org/10.1097/00002093-199205000-00004.

Article  CAS  PubMed  Google Scholar 

Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16(4):203–12. https://doi.org/10.1097/00002093-200210000-00001.

Article  PubMed  Google Scholar 

Beach TG, Adler CH, Sue LI, et al. Arizona study of aging and neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology: official journal of the Japanese Society of Neuropathology. 2015;35(4):354–89. https://doi.org/10.1111/neup.12189.

Article  PubMed  Google Scholar 

Riggs JE, the U.S. Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in, 1977–1986: evidence for an inherently susceptible population subset. Mech Ageing Dev. 1990;55(3):207 – 20. https://doi.org/10.1016/0047-6374(90)90149-a

Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968–1990: increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994;241(7):448–55. https://doi.org/10.1007/BF00900964.

Article  CAS  PubMed  Google Scholar 

Peckeu L, Brandel JP, Welaratne A, Costagliola D, Haïk S. Susceptibility to Creutzfeldt-Jakob disease after human growth hormone treatment in France. Neurology. 2018;91(8):e724–e31. https://doi.org/10.1212/wnl.0000000000006028.

Article  CAS  PubMed  Google Scholar 

Loeuillet C, Boelle PY, Lemaire-Vieille C, et al. Sex effect in mouse and human prion disease. J Infect Dis. 2010;202(4):648–54. https://doi.org/10.1086/654818.

Article  CAS  PubMed  Google Scholar 

Nishimura Y, Harada K, Koyama T, Hagiya H, Otsuka F. A nationwide trend analysis in the incidence and mortality of Creutzfeldt-Jakob disease in Japan between 2005 and 2014. Sci Rep. 2020;10(1):15509. https://doi.org/10.1038/s41598-020-72519-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kimberlin RH, Walker C. Characteristics of a short incubation model of scrapie in the golden hamster. J Gen Virol. 1977;34(2):295–304. https://doi.org/10.1099/0022-1317-34-2-295.

Article  CAS  PubMed  Google Scholar 

Outram GW. The pathogenesis of scrapie in mice. Front Biol. 1976;44:325–57.

CAS  PubMed  Google Scholar 

Watts JC, Giles K, Stöhr J, et al. Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proc Natl Acad Sci U S A. 2012;109(9):3498–503. https://doi.org/10.1073/pnas.1121556109.

Article  PubMed  PubMed Central  Google Scholar 

Watson N, Brandel JP, Green A et al. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.Nature reviews. Neurology. 2021:1–18. https://doi.org/10.1038/s41582-021-00488-7

Casalone C, Zanusso G, Acutis P, et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A. 2004;101(9):3065–70. https://doi.org/10.1073/pnas.0305777101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comoy EE, Casalone C, Lescoutra-Etchegaray N, et al. Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS ONE. 2008;3(8):e3017. https://doi.org/10.1371/journal.po